【24h】

Multifunctional nanoparticles for drug/gene delivery in nanomedicine

机译:用于纳米药物中药物/基因递送的多功能纳米颗粒

获取原文
获取原文并翻译 | 示例

摘要

Multifunctional nanoparticles hold great promise for drug/gene delivery. Multilayered nanoparticles can act as nanomedical systems with on-board "molecular programming" to accomplish complex multi-step tasks. For example, the targeting process has only begun when the nanosystem has found the correct diseased cell of interest. Then it must pass the cell membrane and avoid enzymatic destruction within the endosomes of the cell. Since the nanosystem is only about one millionth the volume of a human cell, for it to have therapeutic efficacy with its contained package, it must deliver that drug or gene to the appropriate site within the living cell. The successive de-layering of these nanosystems in a controlled fashion allows the system to accomplish operations that would be difficult or impossible to do with even complex single molecules. In addition, portions of the nanosystem may be protected from premature degradation or mistargeting to non-diseased cells. All of these problems remain major obstacles to successful drug delivery with a minimum of deleterious side effects to the patient.rnThis paper describes some of the many components involved in the design of a general platform technology for nanomedical systems. The feasibility of most of these components has been demonstrated by our group and others. But the integration of these interacting sub-components remains a challenge. We highlight four components of this process as examples. Each subcomponent has its own sublevels of complexity. But good nanomedical systems have to be designed/engineered as a full nanomedical system, recognizing the need for the other components.
机译:多功能纳米颗粒在药物/基因递送方面具有广阔的前景。多层纳米颗粒可以充当带有机载“分子编程”的纳米医学系统,以完成复杂的多步骤任务。例如,靶向过程仅在纳米系统找到正确的目标患病细胞时才开始。然后,它必须通过细胞膜并避免酶在细胞内体中的破坏。由于纳米系统仅占人类细胞体积的百万分之一,因此要使其具有包含在内的包装的治疗功效,它就必须将该药物或基因传递至活细胞内的适当位置。以受控的方式对这些纳米系统进行连续的分层,使该系统能够完成即使是复杂的单个分子也难以或不可能完成的操作。另外,可以保护纳米系统的一部分免于过早降解或误靶向未患病的细胞。所有这些问题仍然是药物成功交付的主要障碍,给患者带来的有害副作用极小。本文介绍了纳米医学系统通用平台技术设计中涉及的许多组件。我们小组和其他人已经证明了大多数这些组件的可行性。但是,这些相互作用的子组件的集成仍然是一个挑战。我们以该过程的四个组成部分为例。每个子组件都有其自己的复杂性子级别。但是,必须认识到对其他组件的需求,才能将好的纳米医学系统设计/设计为完整的纳米医学系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号